Learning and knowledge sharing are fundamental to the LHSS Project. We invite you to search LHSS knowledge products and resources for the latest approaches, insights, and learning in the field of integrated health systems strengthening.
![Tetun TL FACTSHEET](/sites/default/files/styles/thumbnail/public/2023-12/Tetun%20TL%20Factsheet.png?itok=9-GNn4Ry)
USAID nia Atividade ba Sustentabilidade Sistema Saúde iha Timor-Leste nia objetivu mak atu fortalese governasaun setor saúde, dezenvolve mekanismu ba finansiamentu saúde ida ne’ebe sustentável, fortalese jestaun forsa traballu saúde, promove hahalok saudavel, no mobiliza sosiedade sivil.
![Timor-Leste fact sheet](/sites/default/files/styles/thumbnail/public/2023-12/timor-leste%20factsheet.png?itok=akkv9d-Z)
The USAID Health System Sustainability Activity in Timor-Leste aims to strengthen health sector governance, develop mechanisms for sustainable health financing, strengthen health workforce management, promote healthy behaviors, and mobilize civil society.
![View of stage as attendees listen to the presenter](/sites/default/files/styles/thumbnail/public/2022-03/VN2.png?itok=UbSWlt1U)
This video captures a November 6, 2020 ceremony in Hanoi which marked the formal start of the LHSS Project’s four-year effort to help the Government of Vietnam implement its social health insurance program. The program covers treatment services for people with HIV, among other essential health services.
Working closely with the Vietnam Social Security (VSS) agency, LHSS will help improve the agency’s capacity to manage the insurance program funds effectively, efficiently, equitably, and with accountability. LHSS will also support Vietnam’s transition to full financial ownership of its HIV and TB responses.
![Photo of District Medical Officer interviewed during the video](/sites/default/files/styles/thumbnail/public/2022-03/DrMai.png?itok=u7KSDHaj)
HMED software will improve Vietnam’s capacity to effectively forecast ARV demand, and manage the drugs when they are in the country. Also, engaging drug manufacturers and distributors is crucial to overcoming supply side obstacles.